In order to illustrate the impact of pathological subtype on the prediction for EGFR mutation by the AI model, the same stacked ensemble model was re-tested in adenocarcinoma-only group in the training and testing cohort, respectively. The gene discussed is EGFR; the disease is adenocarcinoma.